News & Updates

Patients with ulcerative colitis at risk for CRC diagnosis, mortality

17 Jan 2020 by

Individuals with ulcerative colitis (UC) appear to be at an elevated risk of developing and dying from colorectal cancer (CRC), despite often presenting at an earlier stage of CRC than those without UC, a recent study showed.

Patients with ulcerative colitis at risk for CRC diagnosis, mortality

17 Jan 2020

Adalimumab biosimilar noninferior to reference product for Crohn’s disease

16 Jan 2020 by

The adalimumab biosimilar BI 695501 shows similar efficacy and safety profile as its reference product in patients with moderate-to-severe Crohn's disease (CD), according to a phase III study recently presented at the Advances in Inflammatory Bowel Diseases (AIBD) 2019 Conference.

Adalimumab biosimilar noninferior to reference product for Crohn’s disease

16 Jan 2020

Bariatric surgery improves joint pain, physical function in obese adolescents

15 Jan 2020 by

Metabolic and bariatric surgery (MBS) decreases the prevalence of musculoskeletal and lower extremity (LE) joint pain and poor physical function in severely obese adolescents, according to the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS*) study.

Bariatric surgery improves joint pain, physical function in obese adolescents

15 Jan 2020

Obeticholic acid heralds a new era for NASH

13 Jan 2020 by

Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.

Obeticholic acid heralds a new era for NASH

13 Jan 2020

H. pylori-eradication therapy improves insulin sensitivity, hepatic steatosis in NAFLD

13 Jan 2020

Helicobacter pylori-eradication therapy in patients with nonalcoholic fatty liver disease (NAFLD) leads to greater improvement in homeostasis model assessment-insulin resistance but exerts comparable effects on hepatic steatosis and liver enzymes as compared with diet and exercise alone, a study has shown.

H. pylori-eradication therapy improves insulin sensitivity, hepatic steatosis in NAFLD

13 Jan 2020

Anti-TNF-α also helps with anaemia in IBD patients

09 Jan 2020

Using anti-tumour necrosis factor-α (TNF-α) agents to treat inflammatory bowel diseases (IBD) also improves haemoglobin levels and may help resolve anaemia, a recent study has shown.

Anti-TNF-α also helps with anaemia in IBD patients

09 Jan 2020

Vedolizumab does not promote malignancies in IBD patients

08 Jan 2020

Use of vedolizumab for inflammatory bowel disease (IBD) does not contribute to an increased incidence of malignancies, with data from the GEMINI LTS study showing that the rate is similar in groups of patients who received the 4- and 8-weekly infusion regimens.

Vedolizumab does not promote malignancies in IBD patients

08 Jan 2020

Severe dysphagia reflects poor outlook in patients with acute HF exacerbation

07 Jan 2020

The presence of dysphagia may independently predict clinical outcomes in patients with acute exacerbation of heart failure (HF), such that the more severe the condition, the higher the in-hospital mortality and the longer the length of hospital stay, as reported in a study.

Severe dysphagia reflects poor outlook in patients with acute HF exacerbation

07 Jan 2020

Antibiotic resistance doubles in just 2 decades in Europe

03 Jan 2020 by

Antibiotic resistance of Helicobacter (H.) pylori has more than doubled in Europe in the past two decades, raising alarm on the gravity of the issue of growing bacterial resistance to commonly-used antibiotics, a study presented at UEG Week 2019 has shown.

Antibiotic resistance doubles in just 2 decades in Europe

03 Jan 2020

BB-12 probiotic may help treat baby colic

30 Dec 2019 by

Supplementation with oral drops containing the probiotic Bifidobacterium animalis subsp. lactis BB‐12 (BB‐12) effectively reduces crying time in infants with colic, suggesting that the gut microbiota can be a target of intervention for infant colic, a study shows.

BB-12 probiotic may help treat baby colic

30 Dec 2019

News & Updates

Filter by Specialty:

Specialty:

Patients with ulcerative colitis at risk for CRC diagnosis, mortality

Patients with ulcerative colitis at risk for CRC diagnosis, mortality

Adalimumab biosimilar noninferior to reference product for Crohn’s disease

Adalimumab biosimilar noninferior to reference product for Crohn’s disease

Bariatric surgery improves joint pain, physical function in obese adolescents

Bariatric surgery improves joint pain, physical function in obese adolescents

Obeticholic acid heralds a new era for NASH

Obeticholic acid heralds a new era for NASH

H. pylori-eradication therapy improves insulin sensitivity, hepatic steatosis in NAFLD

H. pylori-eradication therapy improves insulin sensitivity, hepatic steatosis in NAFLD

Anti-TNF-α also helps with anaemia in IBD patients

Anti-TNF-α also helps with anaemia in IBD patients

Vedolizumab does not promote malignancies in IBD patients

Vedolizumab does not promote malignancies in IBD patients

Severe dysphagia reflects poor outlook in patients with acute HF exacerbation

Severe dysphagia reflects poor outlook in patients with acute HF exacerbation

Antibiotic resistance doubles in just 2 decades in Europe

Antibiotic resistance doubles in just 2 decades in Europe

BB-12 probiotic may help treat baby colic

BB-12 probiotic may help treat baby colic